Jeffrey Nau Ph.D., MMS
Net Worth

Last updated:

What is Jeffrey Nau Ph.D., MMS net worth?

The estimated net worth of Dr. Jeffrey Nau Ph.D., MMS is at least $5,001,600 as of 21 Oct 2021. He has received compensation worth at least $5,001,600 in Oyster Point Pharma, Inc..

What is the salary of Jeffrey Nau Ph.D., MMS?

Dr. Jeffrey Nau Ph.D., MMS salary is $833,600 per year as Pres, Chief Executive Officer & Director in Oyster Point Pharma, Inc..

How old is Jeffrey Nau Ph.D., MMS?

Dr. Jeffrey Nau Ph.D., MMS is 50 years old, born in 1975.

What stocks does Jeffrey Nau Ph.D., MMS currently own?

As insider, Dr. Jeffrey Nau Ph.D., MMS owns shares in one company:

Company Title Shares Price per share Total value
Oyster Point Pharma, Inc. (OYST) Pres, Chief Executive Officer & Director 1,000 $0 $0

What does Oyster Point Pharma, Inc. do?

As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.

OYST logo
OYST
Oyster Point Pharma, Inc.

Jeffrey Nau Ph.D., MMS insider trading

Oyster Point Pharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 50,000 $1.02 $51,000
Option
Employee Stock Option (Right to Buy) 50,000 $1.02 $51,000
Option
Employee Stock Option (Right to Buy) 10,000 $1.02 $10,200
Option
Common Stock 10,000 $1.02 $10,200
Option
Employee Stock Option (Right to Buy) 10,000 $1.02 $10,200
Option
Common Stock 10,000 $1.02 $10,200
Option
Common Stock 10,000 $1.02 $10,200
Option
Employee Stock Option (Right to Buy) 10,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 5,000 N/A N/A
Purchase
Common Stock, par value $0.001 per share 1,000 $16 $16,000

Oyster Point Pharma key executives

Oyster Point Pharma, Inc. executives and other stock owners filed with the SEC:

  • Dr. Jeffrey Nau Ph.D., MMS (50) Pres, Chief Executive Officer & Director
  • Mr. Daniel Lochner M.B.A. (42) Chief Financial Officer
  • Mr. John Snisarenko M.B.A. (61) Chief Commercial Officer